1. Home
  2. THTX vs XGN Comparison

THTX vs XGN Comparison

Compare THTX & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THTX
  • XGN
  • Stock Information
  • Founded
  • THTX 1993
  • XGN 2002
  • Country
  • THTX Canada
  • XGN United States
  • Employees
  • THTX N/A
  • XGN N/A
  • Industry
  • THTX Biotechnology: Pharmaceutical Preparations
  • XGN Medical Specialities
  • Sector
  • THTX Health Care
  • XGN Health Care
  • Exchange
  • THTX Nasdaq
  • XGN Nasdaq
  • Market Cap
  • THTX 144.8M
  • XGN 138.3M
  • IPO Year
  • THTX N/A
  • XGN 2019
  • Fundamental
  • Price
  • THTX $3.29
  • XGN $9.31
  • Analyst Decision
  • THTX Hold
  • XGN Strong Buy
  • Analyst Count
  • THTX 1
  • XGN 5
  • Target Price
  • THTX N/A
  • XGN $12.40
  • AVG Volume (30 Days)
  • THTX 372.3K
  • XGN 210.4K
  • Earning Date
  • THTX 10-09-2025
  • XGN 11-11-2025
  • Dividend Yield
  • THTX N/A
  • XGN N/A
  • EPS Growth
  • THTX N/A
  • XGN N/A
  • EPS
  • THTX N/A
  • XGN N/A
  • Revenue
  • THTX $84,378,000.00
  • XGN $58,862,000.00
  • Revenue This Year
  • THTX N/A
  • XGN $22.09
  • Revenue Next Year
  • THTX $13.76
  • XGN $13.62
  • P/E Ratio
  • THTX N/A
  • XGN N/A
  • Revenue Growth
  • THTX 2.19
  • XGN 3.89
  • 52 Week Low
  • THTX $1.12
  • XGN $2.38
  • 52 Week High
  • THTX $3.31
  • XGN $10.34
  • Technical
  • Relative Strength Index (RSI)
  • THTX 70.36
  • XGN 47.62
  • Support Level
  • THTX $3.26
  • XGN $9.55
  • Resistance Level
  • THTX $3.31
  • XGN $10.28
  • Average True Range (ATR)
  • THTX 0.02
  • XGN 0.39
  • MACD
  • THTX -0.00
  • XGN -0.11
  • Stochastic Oscillator
  • THTX 71.43
  • XGN 11.81

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: